Literature DB >> 25093378

The efficacy and tolerability issue of generics of imatinib in the treatment of chronic myeloid leukemia: do generics really jeopardize patient safety?

Ahmet Emre Eskazan1, Muhlis Cem Ar, Teoman Soysal.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25093378     DOI： 10.3109/10428194.2014.947609

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN： 1026-8022


× No keyword cloud information.
  1 in total

1.  The tolerability issue of generic imatinib in patients with chronic myeloid leukemia (Comment on Adi J. Klil-Drori et al., Haematologica 2019;104(7):e293).

Authors:  Ahmet Emre Eskazan; Teoman Soysal
Journal:  Haematologica       Date:  2019-07       Impact factor: 9.941
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.